Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate α-secretase activity

199Citations
Citations of this article
206Readers
Mendeley users who have this article in their library.

Abstract

ADAM10, a member of a disintegrin and metalloprotease family, is an α-secretase capable of anti-amyloidogenic proteolysis of the amyloid precursor protein. Here, we present evidence for genetic association of ADAM10 with Alzheimer's disease (AD) as well as two rare potentially disease-associated non-synonymous mutations, Q170H and R181G, in the ADAM10 prodomain. These mutations were found in 11 of 16 affected individuals (average onset age 69.5 years) from seven late-onset AD families. Each mutation was also found in one unaffected subject implying incomplete penetrance. Functionally, both mutations significantly attenuated α-secretase activity of ADAM10 (>70% decrease), and elevated Aβ levels (1.5-3.5-fold) in cell-based studies. In summary, we provide the first evidence of ADAM10 as a candidate AD susceptibility gene, and report two potentially pathogenic mutations with incomplete penetrance for late-onset familial AD. © The Author 2009. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Kim, M., Suh, J., Romano, D., Truong, M. H., Mullin, K., Hooli, B., … Tanzi, R. E. (2009). Potential late-onset Alzheimer’s disease-associated mutations in the ADAM10 gene attenuate α-secretase activity. Human Molecular Genetics, 18(20), 3987–3996. https://doi.org/10.1093/hmg/ddp323

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free